Atorvastatin & Fenofibrate Tablets 10 mg/160 mg, 20 mg/160 mg Tablet

What is Atorvastatin & Fenofibrate Tablets 10 mg/160 mg, 20 mg/160 mg Tablet?

Atorvastatin & Fenofibrate Tablets combine two lipid-lowering medicines with complementary mechanisms. Atorvastatin primarily reduces LDL cholesterol production in the liver, while fenofibrate helps lower triglycerides and can influence other lipid parameters. The combination may be used in selected patients with mixed lipid abnormalities when combination therapy is considered appropriate.

Uses / Indications

Atorvastatin & Fenofibrate tablets may be used for:

• Management of mixed dyslipidemia.
• Reduction of elevated LDL cholesterol and triglyceride levels in appropriately selected patients.
• Management of lipid abnormalities when both cholesterol and triglyceride reduction are clinically required.
• Lipid management alongside appropriate dietary and lifestyle measures.

Benefits

• Combines two lipid-modifying agents in one oral tablet.
• Atorvastatin helps reduce LDL cholesterol and other atherogenic lipids.
• Fenofibrate primarily helps reduce elevated triglycerides and may increase HDL cholesterol.
• Provides a combination option for selected patients requiring management of multiple lipid abnormalities.

Side Effects

Common Side Effects

• Headache
• Nausea
• Abdominal discomfort
• Diarrhea or digestive disturbances
• Muscle aches
• Changes in liver enzyme levels

Less Common or Serious Side Effects

• Significant or persistent muscle pain or weakness
• Myopathy or rhabdomyolysis
• Liver injury or significant elevation of liver enzymes
• Gallbladder-related problems
• Pancreatitis, particularly in the context of significant hypertriglyceridemia
• Serious allergic reactions
• Changes in kidney function

How Does It Work?

Atorvastatin inhibits HMG-CoA reductase, an enzyme involved in cholesterol synthesis in the liver. This increases hepatic uptake of LDL particles and lowers circulating LDL cholesterol. Fenofibrate activates peroxisome proliferator-activated receptor alpha (PPAR-α), which promotes fatty-acid oxidation and helps reduce triglyceride-rich lipoproteins. Together, the medicines target different aspects of abnormal lipid metabolism.

Dosage Guidelines

• Take Atorvastatin & Fenofibrate Tablets only as prescribed or recommended by a qualified healthcare professional.
• The appropriate strength and treatment duration depend on lipid levels, treatment goals, kidney and liver function, age, other medicines and individual response.
• Swallow the tablet with water unless otherwise directed.
• Follow the prescribed dosing schedule consistently.
• Do not crush, split, chew or dissolve the tablet unless permitted by the approved product information.
• Continue recommended dietary and lifestyle measures during treatment.
• Regular monitoring of lipid levels and, where clinically appropriate, liver, kidney and muscle-related parameters may be advised.

The exact dose and treatment duration should follow the approved product information and the recommendation of a qualified healthcare professional.

When Not to Use

Atorvastatin & Fenofibrate combination therapy should generally not be used in individuals with:

• Known hypersensitivity to atorvastatin, fenofibrate or relevant formulation components.
• Active liver disease or persistent unexplained elevations of liver transaminases, where contraindicated.
• Severe renal impairment where fenofibrate therapy is contraindicated.
• Gallbladder disease where fenofibrate use is contraindicated.
• Pregnancy.
• Breastfeeding.
• Other conditions specifically identified as contraindications in the approved product information.

Drug / Product Interactions

Important interactions may occur with:

• Other lipid-lowering medicines, particularly certain statins or fibrates.
• Anticoagulants such as warfarin, which may require closer monitoring.
• Certain medicines that increase atorvastatin exposure and may increase muscle-related adverse effects.
• Cyclosporine and some other medicines affecting statin metabolism or transport.
• Medicines that may affect kidney function or increase the risk of muscle toxicity.

A complete medication review should be performed by a qualified healthcare professional before and during combination treatment.

Safety Advice

• Muscle symptoms: Report unexplained or persistent muscle pain, tenderness, weakness or dark urine promptly.
• Liver health: Healthcare professionals may assess liver function where clinically appropriate, particularly if symptoms suggest liver injury.
• Kidney function: Renal function should be considered because fenofibrate dosing depends on kidney function.
• Gallbladder: Inform the healthcare professional about previous gallbladder disease or symptoms suggestive of gallstones.
• Pregnancy: Atorvastatin should not be used during pregnancy. Seek professional advice if pregnancy occurs during treatment.
• Breastfeeding: This combination should not be used during breastfeeding unless the approved product information and healthcare professional specifically indicate otherwise.
• Elderly: Appropriate assessment may be required because the risk of muscle-related adverse effects can be influenced by age and other clinical factors.
• Alcohol: Excessive alcohol consumption may increase concerns regarding liver health and should be discussed with a healthcare professional.
• Driving: Dizziness or other adverse effects may affect some individuals. Avoid driving or operating machinery if affected.
• Overdose: If an overdose is suspected, seek immediate medical attention or contact an appropriate poison-control or emergency medical service.
• Missed dose: Take the missed dose according to the approved dosing instructions. Do not take an extra dose to compensate unless specifically instructed by a healthcare professional.

General Instructions

• Take the medicine exactly according to the prescribed treatment plan.
• Follow the recommended dietary and lifestyle measures for lipid management.
• Inform the healthcare professional about all prescription, non-prescription and herbal medicines being used.
• Report unexplained muscle symptoms, severe abdominal pain, jaundice or dark urine promptly.
• Attend recommended follow-up appointments and laboratory assessments.
• Do not discontinue long-term lipid-lowering treatment without professional guidance.

Special Dietary / Lifestyle Tips

A heart-healthy diet can support lipid management during treatment. Depending on individual requirements, dietary measures may include limiting saturated and trans fats, reducing excessive intake of refined carbohydrates and maintaining an appropriate intake of vegetables, fruits, whole grains and other nutrient-dense foods. Regular physical activity and weight management may also be recommended where appropriate.

Comparison with Other Treatments

Atorvastatin primarily targets LDL cholesterol through inhibition of cholesterol synthesis, while fenofibrate has a stronger effect on triglyceride metabolism. Other lipid-lowering approaches include statin monotherapy, fibrate therapy, ezetimibe and other lipid-modifying medicines. The appropriate treatment depends on the lipid abnormality, cardiovascular risk, treatment response, kidney and liver function, and other clinical factors.

Precautions & Warnings

• Inform the healthcare professional about liver disease, kidney impairment, gallbladder disease or a history of unexplained muscle problems.
• Report persistent or severe muscle pain or weakness, particularly if accompanied by fever or dark urine.
• Inform the healthcare professional about all medicines that may interact with statins or fibrates.
• Periodic lipid monitoring may be required to assess treatment response.
• Liver and kidney function may require assessment according to individual clinical circumstances.
• Avoid use during pregnancy and breastfeeding according to the restrictions applicable to the components of the combination.
• Seek urgent medical attention for severe muscle weakness, severe abdominal pain, jaundice or signs of a serious allergic reaction.

Can I Use It With Other Medicines?

Generally Compatible With

The combination may be used with other medicines when specifically prescribed following an assessment of potential interactions. Compatibility depends on the medicines involved, doses, kidney and liver function and the individual’s clinical condition.

Use With Caution / Avoid

Particular caution may be required with:

• Other statins or fibrates.
• Warfarin and other anticoagulants.
• Cyclosporine.
• Certain medicines that inhibit CYP3A4 or affect atorvastatin transport.
• Medicines associated with increased risk of myopathy or rhabdomyolysis.
• Other medicines that may adversely affect kidney function.

Do not start, stop or change interacting medicines without professional advice.

Storage

Store according to the storage conditions stated on the approved product label and package insert.

• Keep the tablets in the original packaging.
• Protect from excessive heat, moisture and direct light where applicable.
• Keep the pack properly closed when not in use.
• Keep out of reach of children.
• Do not use after the expiry date stated on the packaging.

Frequently Asked Questions

What is Atorvastatin & Fenofibrate Tablets used for?

The combination is used for management of selected lipid disorders, particularly when both elevated cholesterol and triglycerides require treatment.

What is the role of atorvastatin in this combination?

Atorvastatin primarily reduces LDL cholesterol by inhibiting cholesterol synthesis in the liver and increasing hepatic clearance of LDL particles.

What is the role of fenofibrate?

Fenofibrate primarily acts on triglyceride metabolism and can help reduce elevated triglyceride levels while influencing other lipid parameters.

Can Atorvastatin & Fenofibrate cause muscle pain?

Yes. Muscle aches can occur, and rarely more serious muscle injury may develop. Persistent or severe muscle pain or weakness should be reported promptly.

Does this medicine require regular monitoring?

Depending on the individual’s condition, healthcare professionals may monitor lipid levels and may assess liver, kidney or muscle-related parameters when clinically appropriate.

Can this combination be taken with other cholesterol medicines?

Sometimes combination lipid-lowering therapy is prescribed, but the safety of adding another medicine depends on the specific drug and the individual’s clinical circumstances.

Can Atorvastatin & Fenofibrate be used during pregnancy?

Atorvastatin should not be used during pregnancy. This combination should therefore be avoided during pregnancy unless the approved product information specifically provides otherwise, which should be assessed by a qualified healthcare professional.

What should I do if I take too much Atorvastatin & Fenofibrate?

If an overdose is suspected, seek immediate medical attention or contact an appropriate poison-control or emergency medical service.